Abstract The DFNB79 locus harbors TPRN mutations in which have been reported in a few families with deafness. Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family. We identified a Pakistani family in which the affected individuals were homozygous for a pathogenic mutation, c.42_52del11, in TPRN (p.G15Afs150X). In contrast to the previously reported individuals affected by the same mutation, hearing loss is likely to be progressive in this family. Thus the same mutation of TPRN can be associated with different thresholds of hearing as well as differences in the stability of the phenotype.
Introduction
Recessively inherited deafness is typically associated with prelingual and nonprogressive hearing loss. In contrast, dominantly inherited deafness is usually characterized by postlingual onset of hearing loss that is mostly progressive in nature. Findings of progressive hearing loss are less commonly reported in patients with autosomal recessive nonsyndromic hearing loss (Hildebrand et al. 2008 ). More than 65 loci have been localized for nonsyndromic recessively inherited deafness; however, only a few particular recessively inherited mutant alleles of some genes (SLC26A4, TMC1, TMPRSS3, CDH23, GRXCR1, MYO3A, PJVK, LOXHDI, SERPINB6, and GIPC3) cause progressive hearing loss in affected individuals in a small number of families from various world populations (Astuto et al. 2002; Charizopoulou et al. 2011; Elbracht et al. 2007; Grillet et al. 2009; de Heer et al. 2011; Schraders et al. 2010; Schwander et al. 2007; Scott et al. 2001; Sirmaci et al. 2010; Walsh et al. 2002) . The DFNB13 locus is also reported to harbor a gene causing progressive deafness (Mustapha et al. 1998) .
Mutations in only four genes have been implicated in progressive deafness in the Pakistani population. A mutation in TMPRSS3, described in a large extended family, results in postlingual progressive hearing loss in the affected individuals (Scott et al. 2001) . Recently, a missense mutation in PJVK was associated with progressive hearing loss in a family from Pakistan (Mujtaba et al. 2012) . Although not documented, the hearing loss in families with mutations in GIPC3 (Ain et al. 2007; Rehman et al. 2011) and BSND (Riazuddin et al. 2009 ) could be progressive, as the older affected individuals in these families have a more severe hearing loss than that observed in the younger patients in their pedigrees.
TPRN encodes taperin, which is expressed in the organ of Corti in the mouse inner ear (Rehman et al. 2010) . TPRN is localized within the supporting cells and inner ear hair cell stereocilia, where it is present at the taper region of each stereocilium (Rehman et al. 2010) . The four exons of TPRN encode a deduced protein of 711 amino acids. Exon 1 of TPRN is predicted to be a hotspot for mutations because of the presence of repetitive elements high in GC-rich repeats. All the TPRN mutations reported so far are located in exon 1. Four of the five known mutations have been reported in the Pakistani population.
Currently, a single TPRN mutation (c.1347delG) is known to cause rapidly progressive hearing loss in a Dutch family (Li et al. 2010) . Another deletion mutation, c.42_52del11, located in TPRN has been previously reported to cause severe to profound hearing loss in a multiplex Pakistani family (Rehman et al. 2010) . The same mutation was identified in members of a large Moroccan family suffering a severe degree of hearing loss, which is stable in the third decade of life (Li et al. 2010) . We have identified that the c.42_52del11 mutation of TPRN may also be associated with progressive hearing loss.
Materials and Methods
We recruited a small Pakistani nuclear family, HLRB6, from a small village near Sialkot. Three affected children were born in a single consanguineous union (Fig. 1) . Complete medical records of the family were collected, and the family was questioned to exclude syndromic and environmental cases. Romberg and tandem gait tests were conducted to evaluate the vestibular system. Audiological profiling Fig. 1 Characteristics of family HLRB6. a Pedigree of HLRB6 with genotype data at chromosome 9 demonstrating linkage of the phenotype to DFNB79 locus. The location of TPRN relative to the STR markers is also indicated. Solid circles and squares denote affected individuals; dots in open circles and squares denote carriers of the mutation as determined by sequencing and genotyping. Alleles: ? denotes wild-type allele of TPRN with two complete repetitive units in exon 1; -shows the deletion of one of these two repeats (i.e., the mutant allele); gray shading denotes the deafness-linked haplotype. On the far left, the haplotype of a previously described individual from family PKDF1129 with the same TPRN mutation is provided for comparison with that observed for HLRB6. Marker distances (cM) according to the Rutgers combined genetic map. C9S2168 is a self-designed STR marker located upstream of D9S2168, at physical position chr9:141001671-141001719 (Feb 2009 GRCh37/hg19). b Pure-tone audiograms for two affected individuals of family HLRB6, showing moderate to profound hearing loss for 13-year-old V:2 (dotted line) and 17-year-old V:1 (solid line). Hearing thresholds of right ear are marked by circles, left ear by crosses. c Electropherograms revealed an 11-nucleotide deletion (c.42_52del11) in TPRN in the DNA of all affected individuals. Triangle indicates the start of deletion. R1 and R2 indicate the first and second consecutive GC-rich repeats in the sequence of the affected individuals was done using previous records, interrogations, and fresh audiometric examinations. Current audiological examinations were performed on two affected individuals, V:1 (17 years old) and V:2 (13 years old), with measurements of both bone and air conduction by pure tone audiometry in ambient noise conditions. Audiometry was repeated for V:2 at the age of 14 years. Unfortunately, a sound-proof room was not available for conducting these tests, and facilities for recording ABR did not exist in the vicinity.
Blood samples were collected after obtaining approval of the institutional review board at the School of Biological Sciences, University of the Punjab, Lahore, and written informed consent of the participants. Genomic DNA was extracted from blood samples (Grimberg et al. 1989) . DFNB1 was excluded by direct sequencing of GJB2. The other 40 known deafness genes including TPRN were screened by homozygosity mapping with fluorescently labeled microsatellite markers as described previously (Imtiaz and Naz 2012) . Fifty consanguineous families with at least three affected individuals and 57 affected sporadic cases, born in consanguineous unions with moderate to severe hearing loss, were also screened for linkage to or homozygosity for three STR markers specific for DFNB79 (D9S1826, D9S158, and D9S1838). Among these, affected individuals in 10 % of the families presented with deafness inferred to be progressive in nature. The phenotypic and genotypic details of all the families and sporadic cases in this cohort will be described elsewhere (Naz et al, manuscript in preparation) .
The four exons of TPRN were PCR amplified and sequenced in order to identify the underlying mutation. To identify carriers for c.42_52del11 in the normal Pakistani population, primers 5 0 FAM-GCGGGCTTTCCCCAATGGTC and 5 0 -CCGGGCACCGTCTCGATGAT were used for amplification of the product spanning the deletion and analyzed as previously described . In brief, the c.42_52del11 mutation was screened in 100 ethnically matched controls (200 chromosomes), using size fractionation of the PCR products spanning this region by capillary electrophoresis. Similarly, DNA from all unaffected members of family HLRB6 was screened to determine carrier status for the deletion.
A DNA sample of an affected individual from a previously described family, PKDF1129 (Rehman et al. 2010) , was genotyped with five STR markers spanning TPRN to determine if the mutation detected for family HLRB6 had a common origin in the two families.
Results
Detailed medical histories and physical examinations revealed normal development and absence of environmental and syndromic causes of hearing loss in affected individuals of family HLRB6. Tandem walking was normal, and the Romberg test was also negative among affected children, suggesting normal vestibular function. According to the parents, the onset of hearing loss was noticed by 2 years of age. Audiometry was performed both at the time of admission to school and as part of this research. Initial audiometric details provided by the school for the two older affected children of family HLRB6 stated that at the time of admission, individuals V:1 (9 years old) and V:2 (7 years old) had a moderate degree of hearing loss.
Unfortunately, the school did not maintain the data in the form of audiograms with hearing thresholds recorded at various frequencies. The current audiograms of the two affected individuals revealed moderate to profound hearing loss (Fig. 1) . The third child (V:4) was too young (5 years) for audiometric examination but had significantly better hearing than the older affected siblings, as ascertained by sound perception and presence of good oral communication skills. None of the affected individuals wears hearing aids. Recently, the ears of all affected individuals were re-examined by an ear-nose-throat doctor. The examination revealed that the tympanic membranes of the eldest (V:1) and youngest (V:4) affected individuals were intact but slightly hyperemic, which precluded reassessment by audiometry. The tympanic membrane of individual V:2 was normal. There was no significant change in the audiological profile of V:2 from that recorded 1 year ago (Fig. 1) .
Residual hearing was observed in the affected children. The oldest affected individual (V:1), at 17 years of age, had the most severe hearing loss, with greater involvement of high frequencies compared with his 13-year-old sibling (V:2). Although there is no audiometric documentation of the progression of deafness, the records pertaining to the hearing thresholds of the affected individuals maintained at the school, comparisons of degree of hearing loss among the siblings, and selfreports by the patients strongly support that deafness is progressive. It is interesting to note that the loss in hearing is quite similar at low frequencies, and dramatic shifts of 20-30 dB are observed between the siblings at frequencies of 2-4 kHz. This suggests that hearing at high frequencies worsens rapidly, while loss of hearing at lower frequencies may be more gradual.
Genotyping excluded all loci of hearing loss except for DFNB79 for this family. Alleles of four markers (D9S1826, D9S158, D9S1838, and C9S2168) on chromosome 9 were homozygous for all affected individuals (Fig. 1) . A maximum two-point LOD score of 2.0 was obtained at recombination fraction h = 0 for markers D9S1826 and D9S1838. A homozygous 11 bp deletion, c.42_52del11 (p.G15Afs150X), was identified in the first exon of TPRN in the DNA samples of all affected individuals of family HLRB6 (Fig. 1) . The mutation deletes one of the two 11 bp GC-rich tandemly repeated sequences from the TPRN gene. All other unaffected family members of HLRB6, except for V:3, were heterozygous carriers of the mutation (Fig. 1) . A previously described family, PKDF1129 from Pakistan, with the same c.42_52del11 mutation in TPRN (Rehman et al. 2010) did not share the same haplotype for markers spanning TPRN as that observed for family HLRB6 (Fig. 1) .
Hearing loss in no other family was linked to DFNB79, and none of the sporadic individuals was homozygous for markers spanning TPRN. This suggests that TPRN is not a significant contributor to moderate to severe hearing loss in the Pakistani population, although its contribution to progressive hearing loss remains to be determined.
Discussion
Since the initial reports of mutations in TPRN, this is the first independent finding of a TPRN mutation in recessive hearing loss. The mutation c.42_52del11 (p.G15Afs150X) has been previously reported in families from Pakistan and Morocco (Rehman et al. 2010; Li et al. 2010) . Since the sizes of the linked alleles of the closest STR markers spanning TPRN in affected individuals in the two Pakistani families differ considerably, the mutation c.42_52del11 most likely arose independently in the two pedigrees. It was previously hypothesized that this region of TPRN is a hotspot for mutations because of the presence of GC-rich repetitive elements (Rehman et al. 2010) . This is further supported by our data. Thus, the c.42_52del1 mutation may be a recurrent contributor to hearing loss, at least in the Pakistani population, due to this mutational hotspot.
Two different mutations in one gene, or the presence of identical mutations in one gene, have been described to cause inter-or intrafamilial variability of hearing loss previously (Astuto et al. 2002; Bashir et al. 2010 ). This variability of hearing loss can be explained on the basis of severity of the mutations or the presence of modifiers. The c.42_52del11 is most likely to be a null mutation. Therefore, its involvement in progressive hearing loss in a family from Pakistan and in stable hearing loss phenotype in another Pakistani and a Moroccan family strongly suggests the presence of a genetic modifier. To date, all reported mutations of TPRN are located in the first exon (Table 1) . Sequencing of this exon may be considered in recessively inherited cases of nonsyndromic hearing loss, especially if signs of progression are present since two of the known mutations can be associated with progressive hearing loss (Li et al. 2010 and current work).
Age-dependent hair cell damage seems to be a common mechanism for progressive autosomal recessive hearing loss (Grillet et al. 2009 ). Taperin is localized to the hair cells, as are other gene products reported to cause progressive hearing loss. As TPRN function is still unknown, the mechanism of progression of hearing loss cannot be predicted, but its involvement in the progressive phenotype suggests its additional secondary role in either maintenance or protection of hair cells. Our study further supports that TPRN mutations must be considered when studying the etiology of progressive hearing loss. Understanding the genetic basis of progressive deafness can lead to development of therapies to stop or delay further progression of hearing loss and can also lead to early diagnosis. 
